Violytic App
Violytic App @violytic ·
The correlation Jennifer found that surprised us most: Screen time after 10 PM → higher flare probability 36 hours later. Not diet. Not stress. Sleep disruption from screens. We never would have guessed without the data. #HS #ChronicIllness #SymptomTracking
106
Dermatology Times
Dermatology Times @DermTimesNow ·
👥🌄 In new long-term BE HEARD trial data presented at #AAD2026, #bimekizumab showed durable #HS control, with ~86% flare-free at 3 years. hubs.li/Q048FglH0W3 #HidradenitisSuppurativa #DermTwitter
Long-term BE HEARD Data Show Durable HiSCR Responses With Bimekizumab in HS | Dermatology Times
Long-term BE HEARD Data Show Durable HiSCR Responses With Bimekizumab in HS | Dermatology Times

BE HEARD extension data underscore the importance of early diagnosis and treatment initiation to optimize long-term outcomes in hidradenitis suppurativa.

From dermatologytimes.com
218
化膿性汗腺炎(慢性膿皮症)Wiki
化膿性汗腺炎(慢性膿皮症)Wiki @hs_patient_wiki ·
Replying to @hs_patient_wiki
【HSインタビュー・あと1名募集中】 「PCがないとダメだと思ってた」という声を頂きました 実は本調査スマホやタブレットでの参加も大歓迎です! ZOOMアプリがあればどこからでもお話し頂けます ✅謝礼1.5万円 最後の1枠詳細はこちら👇hs.megabbs.info/archives/6087.…t #化膿性汗腺 #HS
あなたの声が新薬を創る!化膿性汗腺炎インタビュー協力者募集【HSみらい共創プロジェクト第1弾】

【HSみらい共創プロジェクト第1弾】海外大手製薬企業の新薬開発に向けた、化膿性汗腺炎(HS)患者様対象のオンラインインタビュー募集です。対象は治療中で症状が複数ある方(謝礼あり)。あなたのリアルな経験が、未来の治療を変える大きな力になります。詳細はこちら。

From hs.megabbs.info
161
Violytic App
Violytic App @violytic ·
The hardest part of building Violytic was this: I had to watch Jennifer flare while we iterated. Every bug wasn't just a product issue. It was a bad night for her. That's the kind of motivation that doesn't let you quit. #HS #BuildingInPublic
137
TiinaTrezzi 🇫🇮+🇮🇱+🇺🇦+🎗️+✝️+✡️
TiinaTrezzi 🇫🇮+🇮🇱+🇺🇦+🎗️+✝️+✡️ @Gampsu ·
#yle #mtv3 #hs #eduskunta #ps #vihreät #vasemmisto #KD #Keskusta Mukavaa kuunnella vaihteeksi totuutta YK:n suunnalta...🤓
Kosher Kosher @koshercockney ·
Best Speech at the UN I’ve watched in a long time wow. You gotta listen to this by Kuwaiti dissident @JJJuraid x.com/UNWatch/status… Mr. Chair, I heard the term “colonizers.” But who are the real colonizers? A Jewish Kingdom ruled in Judea for a thousand years. We, the Arabs, took this land. Who Arabized Egyptians, Phoenicians, Persians and Amazighs? It was us, the Arabs. So why does the council enshrine a lie by keeping a permanent agenda item on Palestine, while ignoring the indigenous heart of Israel returning home? Let us be clear about who is actually defending our sovereignty. Today, Israel is a fighter for peaceful nations, freeing Gaza from Hamas and saving Iranians from the Islamic Republic. What Israel is doing to the IRGC — stopping a genocidal regime from acquiring nuclear weapons — is a gift to humanity. There are 57 Islamic countries and only one Jewish state, Israel. Despite the ongoing hateful desire to eliminate it, Israel has not only survived, it has thrived. I don't believe in miracles, but this is one. So I ask the UN: when will you end the ritual of condemning Israel? Is it not time, instead, to learn from Israel? How to defeat terror, defend free societies, and pursue peace. Thank you.
188
Violytic App
Violytic App @violytic ·
HS affects people differently. Stage I. Stage II. Stage III. Different locations. Different triggers. Different severity. That's why there's no one-size treatment. And no one-size tracker. Violytic adapts to your pattern. #HS #HidradenitisSuppurativa
100
化膿性汗腺炎(慢性膿皮症)Wiki
化膿性汗腺炎(慢性膿皮症)Wiki @hs_patient_wiki ·
【緊急】 インタビュー募集定員に達しておりましたが参加予定の方に急遽入院が発生し【残り1枠】空きが出ました。 HSの未来を創る「最後の一人」としてお力を貸して頂けませんか? ✅謝礼1.5万円 ✅ZOOM形式 詳細👇 hs.megabbs.info/archives/6087.…t #化膿性汗腺 #HS
あなたの声が新薬を創る!化膿性汗腺炎インタビュー協力者募集【HSみらい共創プロジェクト第1弾】

【HSみらい共創プロジェクト第1弾】海外大手製薬企業の新薬開発に向けた、化膿性汗腺炎(HS)患者様対象のオンラインインタビュー募集です。対象は治療中で症状が複数ある方(謝礼あり)。あなたのリアルな経験が、未来の治療を変える大きな力になります。詳細はこちら。

From hs.megabbs.info
1
230
misha
misha @serkeettic ·
starstuck?? homewars???.. clue: horns #swtwt #hs
1
7
404
Violytic App
Violytic App @violytic ·
I built Violytic because the symptom diary apps we tried were built for diabetes, not HS. Wrong disease model. Wrong fields. Wrong assumptions. HS deserves a tool built specifically for HS. #HS #HidradenitisSuppurativa #HealthTech
131